|
Volumn 360, Issue 9, 2009, Pages 933-935
|
Genetically elevated C-reactive protein and vascular disease
|
Author keywords
[No Author keywords available]
|
Indexed keywords
C REACTIVE PROTEIN;
APOLIPOPROTEIN E;
CHOLESTEROL;
BIOLOGICAL MARKER;
CONFIDENCE INTERVAL;
DISEASE ASSOCIATION;
GENETIC DISORDER;
GENETIC POLYMORPHISM;
GENOTYPE;
HAZARD RATIO;
HUMAN;
ISCHEMIC HEART DISEASE;
LETTER;
MULTIVARIATE ANALYSIS;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RANDOMIZATION;
RISK FACTOR;
VASCULAR DISEASE;
CARDIOVASCULAR RISK;
CLINICAL EVALUATION;
PLEIOTROPY;
PREDICTION;
CHOLESTEROL BLOOD LEVEL;
DENMARK;
UNITED STATES;
ATHEROSCLEROSIS;
BLOOD;
GENETIC PREDISPOSITION;
GENETICS;
HEART MUSCLE ISCHEMIA;
NOTE;
APOLIPOPROTEINS E;
ATHEROSCLEROSIS;
BIOLOGICAL MARKERS;
C-REACTIVE PROTEIN;
GENETIC PREDISPOSITION TO DISEASE;
GENOTYPE;
HUMANS;
MYOCARDIAL ISCHEMIA;
POLYMORPHISM, GENETIC;
RISK FACTORS;
|
EID: 61449111017
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMc082413 Document Type: Letter |
Times cited : (5)
|
References (5)
|